#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3579954	Binding	Inhibition of human placental HexB using MUGS substrate incubated for 1 to 2 hrs at pH 4.5 by spectrofluorometry	Homo sapiens	2	ALA3576868	assay format	Scientific Literature
2.	ALA3579968	Binding	Inhibition of human placental HexB using MUGS substrate incubated for 1 to 2 hrs at pH 7.0 by spectrofluorometry	Homo sapiens	2	ALA3576868	assay format	Scientific Literature
3.	ALA1250605	Binding	Inhibition of human placental lysosomal hexosaminidase B at 5 uM	Homo sapiens	3	ALA1250539	assay format	Scientific Literature
4.	ALA4355748	Binding	Inhibition of human beta hexosaminidase assessed as inhibitory constant using 4-methylumbelliferyl 2-acetamido-2-deoxy-beta-D-glucopyranoside as substrate incubated for 30 mins by fluorescence spectrophotometry	Homo sapiens	1	ALA4354805	single protein format	Scientific Literature
5.	ALA4355756	Binding	Inhibition of human beta hexosaminidase assessed as inhibitory constant using 4-methylumbelliferyl N-acetyl-beta-D-glucosaminide dihydrate as substrate measured every 60 sec for 45 mins by fluorescence spectrophotometry	Homo sapiens	41	ALA4354805	single protein format	Scientific Literature
6.	ALA986741	Binding	Increase in thermostability of beta Hex A betaR505Q mutant isolated from Sandhoff disease patient assessed as residual enzyme activity at 3 ug/ml at 37 degC after 30 mins relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
7.	ALA986742	Binding	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
8.	ALA986743	Binding	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
9.	ALA986744	Binding	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
10.	ALA986745	Binding	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
11.	ALA986746	Binding	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
12.	ALA986747	Binding	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
13.	ALA986748	Binding	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
14.	ALA986749	Binding	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
15.	ALA986754	Binding	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
16.	ALA983111	Binding	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
17.	ALA983112	Binding	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
18.	ALA983113	Binding	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
19.	ALA983118	Binding	Pharmacological chaperone effect on beta Hex A beta-P504S/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature
20.	ALA983119	Binding	Pharmacological chaperone effect on beta Hex A beta-P504S/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1	ALA1156436	single protein format	Scientific Literature